Ten percent owner Jorey Chernett boosts Neuronetics (STIM) stake with 385K-share buy
Rhea-AI Filing Summary
Neuronetics, Inc. ten percent owner Jorey Chernett reported an open-market purchase of 385,442 shares of common stock at a weighted average price of $1.25 per share. After this transaction, Chernett directly beneficially owned 9,778,988 shares of Neuronetics common stock.
The shares were acquired in multiple trades at prices ranging from $1.23 to $1.26 per share, calculated on a weighted average basis. The filing also corrects a prior clerical error, noting that the previously reported beneficial ownership had been understated by 270 shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 385,442 | $1.25 | $482K |
Footnotes (1)
- The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $1.23 to $1.26, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased. This amount corrects a clerical error in the Reporting Person's Form 4 previously filed on March 30, 2026, in which the number of shares beneficially owned by the Reporting Person was under-reported by 270 shares.
Key Figures
Key Terms
weighted average price financial
beneficially owned financial
open-market purchase financial
ten percent owner financial
FAQ
What did Jorey Chernett do in the latest Form 4 for STIM?
What does the clerical error correction mean in the STIM Form 4?